Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients

Overview of attention for article published in Frontiers in Pharmacology, December 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,307 followers.

Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients https://t.co/LaX8zfSfEl

Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients. https://t.co/hb2PrC0DbW #longqt #cardiotwitter #epeeps

Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients https://t.co/lHMZlF8p4k

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.